(22) or in our current NAFLD study, these findings revealed that the ALT/HDL-C ratio significantly improved the identification/prediction ability of chronic diseases compared to ALT or HDL-C alone. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.